Dr. Heidenberg on whether HoLEP study data will influence technique
“I don’t think anybody, at least in our Mayo Clinic practices, is ever doing anything other than apical release HoLEPs these days,” says Daniel J. Heidenberg, MD.
“I don’t think anybody, at least in our Mayo Clinic practices, is ever doing anything other than apical release HoLEPs these days,” says Daniel J. Heidenberg, MD.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
“When we looked at the risk of bleeding and takeback for fulguration, the reported rate was 0.46%. Less than 1% of patients had any significant…
Even in the United States, women with chronic kidney disease (CKD) are receiving less than optimal care.
Rana McKay discusses the NePtune study, investigating PARP inhibitors as a neoadjuvant treatment for prostate cancer patients with BRCA1/2 mutations. This study, inspired by the…
The American Urological Association (AUA) published the white paper, Catheter-Associated Urinary Tract Infections: Definitions and Significance in the Urologic Patient, in 2014. At that time,…
RAG-01 is an saRNA therapy that is delivered via intravesical instillation and is designed to target and activate p21, a tumor suppressor gene.
“We saw that Black men within this cohort had lower Decipher scores across all ages and Gleason scores different than what had been reported in…
Use of prostate-specific membrane antigen positron emission tomography to determine disease extent provides a novel method for risk stratification for patients with nonmetastatic castration-resistant prostate…
Anger adversely affects endothelium-dependent vasodilation, indicated by change in reactive hyperemia index
“We were deeply impressed by Galen’s performance in the study, that based on our validation, clearly showed how Ibex can support our clinicians in improving…